CICERI, FABIO
 Distribuzione geografica
Continente #
EU - Europa 22.704
AS - Asia 22.219
NA - Nord America 14.286
SA - Sud America 5.970
AF - Africa 508
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 65.749
Nazione #
US - Stati Uniti d'America 13.616
RU - Federazione Russa 13.213
SG - Singapore 8.843
CN - Cina 6.160
BR - Brasile 4.882
HK - Hong Kong 2.869
IT - Italia 2.659
SE - Svezia 2.293
VN - Vietnam 2.243
FR - Francia 1.156
DE - Germania 854
GB - Regno Unito 549
IN - India 473
AR - Argentina 428
FI - Finlandia 330
NL - Olanda 302
CA - Canada 298
RO - Romania 279
AT - Austria 254
MX - Messico 234
BD - Bangladesh 220
JP - Giappone 220
EC - Ecuador 196
ZA - Sudafrica 187
ID - Indonesia 172
PL - Polonia 172
TR - Turchia 170
IQ - Iraq 166
ES - Italia 158
IE - Irlanda 143
CO - Colombia 107
PY - Paraguay 99
PK - Pakistan 89
CL - Cile 77
VE - Venezuela 75
UA - Ucraina 71
SA - Arabia Saudita 70
MA - Marocco 65
UZ - Uzbekistan 62
LT - Lituania 61
EG - Egitto 55
PH - Filippine 50
TN - Tunisia 47
AU - Australia 45
DZ - Algeria 45
UY - Uruguay 44
PE - Perù 41
AE - Emirati Arabi Uniti 38
IL - Israele 36
IR - Iran 35
KE - Kenya 32
JO - Giordania 31
BE - Belgio 29
NP - Nepal 28
MY - Malesia 27
AZ - Azerbaigian 26
DO - Repubblica Dominicana 26
KR - Corea 26
KZ - Kazakistan 25
CH - Svizzera 21
LB - Libano 20
AL - Albania 17
CZ - Repubblica Ceca 16
ET - Etiopia 16
JM - Giamaica 16
BY - Bielorussia 15
PA - Panama 15
PT - Portogallo 15
TH - Thailandia 15
TW - Taiwan 15
BO - Bolivia 14
HN - Honduras 14
CR - Costa Rica 12
DK - Danimarca 12
TT - Trinidad e Tobago 12
OM - Oman 11
SY - Repubblica araba siriana 11
NI - Nicaragua 10
PS - Palestinian Territory 10
SV - El Salvador 10
BA - Bosnia-Erzegovina 9
BG - Bulgaria 9
BH - Bahrain 9
CI - Costa d'Avorio 9
GR - Grecia 9
KW - Kuwait 9
HR - Croazia 8
HU - Ungheria 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
AO - Angola 7
BW - Botswana 7
GT - Guatemala 7
NO - Norvegia 7
RS - Serbia 7
SN - Senegal 7
CY - Cipro 6
GE - Georgia 6
LK - Sri Lanka 6
LV - Lettonia 6
Totale 65.650
Città #
Singapore 3.952
Moscow 2.893
Hong Kong 2.832
Ashburn 2.115
Dallas 1.987
San Jose 1.782
Shanghai 1.325
Hefei 1.096
Lauterbourg 945
Lawrence 812
Princeton 811
Ho Chi Minh City 794
Milan 715
Beijing 706
New York 622
Hanoi 478
São Paulo 461
Los Angeles 380
Nuremberg 252
Boardman 231
Rome 214
Santa Clara 194
Munich 176
Helsinki 163
Orem 158
Rio de Janeiro 157
Tokyo 150
Warsaw 142
Dublin 130
Brooklyn 125
Chennai 122
Vienna 119
Denver 118
Guangzhou 117
Montreal 114
Belo Horizonte 110
Johannesburg 108
London 105
Washington 105
Da Nang 104
Stockholm 101
Haiphong 98
Cesano Boscone 96
Poplar 93
Council Bluffs 90
Manchester 89
Lappeenranta 88
Frankfurt am Main 87
Curitiba 83
Atlanta 82
Brasília 82
Amsterdam 78
Brescia 77
Seattle 77
Mexico City 76
Ankara 75
Phoenix 75
Chicago 74
Guayaquil 72
Turku 71
Toronto 70
Campinas 69
Pune 69
Quito 67
The Dalles 66
Boston 64
Baghdad 62
Castelseprio 61
Houston 57
Porto Alegre 57
Salvador 56
Tashkent 56
Biên Hòa 53
Hải Dương 52
Bologna 51
Hangzhou 51
Mumbai 46
Shenzhen 46
Tianjin 46
Turin 44
Guarulhos 42
Dhaka 41
Goiânia 41
Santo André 41
Buenos Aires 39
Jakarta 39
Columbus 37
Montevideo 36
Thái Bình 36
Querétaro 35
San Francisco 35
Bergamo 33
Ribeirão Preto 33
Manaus 32
Sorocaba 32
Monza 31
Shijiazhuang 31
Naples 30
New Delhi 30
Amman 29
Totale 31.430
Nome #
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 382
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 372
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 217
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 213
Use of HSV-TK transduced donor lymphocytes in the context of allogeneic bone marrow transplantation: A paradigm of current applications and limitations in gene therapy 212
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations 187
Loss of mismatched HLA in leukemia after stem-cell transplantation 182
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 173
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 165
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 165
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 161
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 161
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 161
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 160
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 160
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 158
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 158
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 157
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 156
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 152
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 151
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 148
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation 146
A New Clinicobiological Scoring System for the Prediction of Infection-Related Mortality and Survival after Allogeneic Hematopoietic Stem Cell Transplantation 146
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 145
Biobanking for COVID-19 research 144
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 141
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 140
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 140
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 139
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 136
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 135
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 134
A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells 134
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia 134
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 133
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 133
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 132
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 130
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 129
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 128
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 128
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 127
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 126
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus 125
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 125
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 124
Physical and psychological sequelae at three months after acute illness in COVID-19 survivors 124
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 123
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 123
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study 123
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 122
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study 122
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients 121
Long-term lineage commitment in haematopoietic stem cell gene therapy 120
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 120
CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature 120
A T cell epitope encoded by a subset HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation 120
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 119
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 119
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
One-year mental health outcomes in a cohort of COVID-19 survivors 118
A phase II multicenter trial of HSV-TK engineered donor lymphocytes after haplo-identical HSCT: Early immune reconstitution and abrogation of GvHD 117
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 116
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 116
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 116
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 115
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias 115
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 115
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 114
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 114
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 114
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 113
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation 113
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 113
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 113
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 111
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 110
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 110
A dual role for genetically modified lymphocytes in cancer immunotherapy 110
COVID-19 mortality rate in nine high-income metropolitan regions 110
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 109
CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade 109
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 108
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 108
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 108
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 108
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 107
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party 107
Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients 107
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 107
Subclinical myocardial dysfunction in patients recovered from COVID-19 107
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 107
Totale 13.814
Categoria #
all - tutte 408.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 408.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 1 13 4
2021/2022751 11 2 8 240 55 36 65 102 57 90 27 58
2022/20234.925 1.762 862 248 92 190 567 209 334 392 76 113 80
2023/20243.456 201 226 396 356 327 626 192 273 29 137 179 514
2024/202515.321 1.666 466 330 469 478 1.261 2.153 1.449 2.453 2.072 1.175 1.349
2025/202642.191 3.269 3.468 3.223 6.709 3.355 1.291 4.338 3.158 11.751 1.629 0 0
Totale 67.173